QF-CMV Launched
Product Manager appointed
•
EU, ROW initial regions -CE marked and cleared
•
US FDA application will follow
•
Will be launched through major US transplant conferences this FY
Market size
•
~ 70,000 solid organ transplants p.a. –multiple tests per patient
•
Expected time to market peak 3-5yrs (no incumbent competitor)
- Forums
- ASX - By Stock
- CST
- sales $34.461 million, eps 8.57c, div 2c
sales $34.461 million, eps 8.57c, div 2c, page-7
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist